COEP
NASDAQ · Biotechnology
Coeptis Therapeutics Holding
$9.84
-1.46 (-12.92%)
Open$11.38
Previous Close$11.30
Day High$11.47
Day Low$9.00
52W High$21.41
52W Low$6.80
Volume—
Avg Volume171.4K
Market Cap102.06M
P/E Ratio—
EPS$-0.88
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.06M | 8.74M | 7.84M |
| Net Income | -17,995,573 | -2,031,310 | -1,359,886 |
| Profit Margin | -874.3% | -23.2% | -17.3% |
| EBITDA | -18,585,812 | -2,389,064 | -2,398,436 |
| Free Cash Flow | — | -1,186,852 | -1,098,506 |
| Rev Growth | — | +14.6% | -0.2% |
| Debt/Equity | 0.02 | 0.28 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |